MedPath

广州欧化药业有限公司

Ownership
-
Established
1993-12-29
Employees
-
Market Cap
-
Website
http://gzouhua.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

复方血栓通颗粒

Approval Number
国药准字Z20113064
Approval Date
May 23, 2023
NMPA

Clotrimazole Tablets

Product Name
克霉唑片
Approval Number
国药准字H44022607
Approval Date
May 19, 2020
NMPA

Diclofenac Sodium Enteric-coated Tablets

Product Name
双氯芬酸钠肠溶片
Approval Number
国药准字H44024839
Approval Date
May 15, 2020
NMPA

Pediatric Paracetamol, Atificial Cow-bezoar and Chlorphenamine Maleate Tablets

Product Name
小儿氨酚黄那敏片
Approval Number
国药准字H44024372
Approval Date
May 15, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H44024926
Approval Date
May 15, 2020
NMPA

Vitamin E Nicotinicate Capsules

Product Name
维生素E烟酸酯胶囊
Approval Number
国药准字H44024840
Approval Date
May 13, 2020
NMPA

Taurine Capsules

Product Name
牛磺酸胶囊
Approval Number
国药准字H44024673
Approval Date
Apr 29, 2020
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H44022635
Approval Date
Apr 29, 2020
NMPA

Carbocisteine Tablets

Product Name
羧甲司坦片
Approval Number
国药准字H44022609
Approval Date
Apr 29, 2020
NMPA

Fenofibrate Capsules

Product Name
非诺贝特胶囊
Approval Number
国药准字H44022634
Approval Date
Apr 29, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.